Furthermore, in other periodic fever syndromes, such as TRAPS, CAPS and HIDS, IL-1 receptor antagonist anakinra and anti-TNF agents have proven effective in controlling symptoms, whereas colchicine is ineffective in preventing and treating attacks [18]. Here, TNF is linked to cryopyrin-associated periodic syndrome.